Early Human Cytomegalovirus Reactivation Is Associated With Lower Incidence of Relapse of Myeloproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation

Researchers studying cytomegalovirus (CMV) and myeloproliferative disorders found that a substantial reduction in relapse of myeloproliferative disorders is associated with CMV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Bone Marrow Transplantation